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Abstract
Background: Garlic has been used for centuries for its flavour and health promoting properties that include
protection against cancer. The vinyl disulfide-sulfoxide ajoene is one of the phytochemicals found in crushed
cloves, hypothesised to act by S-thiolating reactive cysteines in target proteins.
Methods: Using our fluorescently labelled ajoene analogue called dansyl-ajoene, ajoene’s protein targets in MDA-
MB-231 breast cancer cells were tagged and separated by 2D electrophoresis. A predominant band was identified
by MALDI-TOF MS/MS to be vimentin. Target validation experiments were performed using pure recombinant
vimentin protein. Computational modelling of vimentin bound to ajoene was performed using Schrödinger and
pKa calculations by Epik software. Cytotoxicity of ajoene in MDA-MB-231 and HeLa cells was measured by the MTT
assay. The vimentin filament network was visualised in ajoene-treated and non-treated cells by
immunofluorescence and vimentin protein expression was determined by immunoblot. The invasion and migration
activity was measured by wound healing and transwell assays using wildtype cells and cells in which the vimentin
protein had been transiently knocked down by siRNA or overexpressed.
Results: The dominant protein tagged by dansyl-ajoene was identified to be the 57 kDa protein vimentin. The
vimentin target was validated to reveal that ajoene and dansyl-ajoene covalently bind to recombinant vimentin via
a disulfide linkage at Cys-328. Computational modelling showed Cys-328 to be exposed at the termini of the
vimentin tetramer. Treatment of MDA-MB-231 or HeLa cells with a non-cytotoxic concentration of ajoene caused
the vimentin filament network to condense; and to increase vimentin protein expression. Ajoene inhibited the
invasion and migration of both cancer cell lines which was found to be dependent on the presence of vimentin.
Vimentin overexpression caused cells to become more migratory, an effect that was completely rescued by ajoene.
Conclusions: The garlic-derived phytochemical ajoene targets and covalently modifies vimentin in cancer cells by
S-thiolating Cys-328. This interaction results in the disruption of the vimentin filament network and contributes to
the anti-metastatic activity of ajoene in cancer cells.
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Background
Garlic (Allium sativum) has been used since ancient times
as a food additive and for its beneficial health effects that
include protection against cancer [1]. The bioactivity of
garlic is attributed to a collection of sulfur-containing
polysulfanes that are released when the clove is damaged
in chemical defence against the invasive threat. In whole,
undamaged cloves, the enzyme allinase and its substrate
alliin are separated into compartments; however, when the
clove is damaged, the allinase and its substrate come into
contact to produce allicin. Allicin is unstable, and able to
readily undergo thiol/disulfide exchange, or to eliminate
to form a number of more stable secondary metabolites
that constitute aged or heated garlic preparations [2, 3].
Ajoene (E/Z- 4,5,9-trithiadodeca-1,6,11-triene 9-oxide)
(see Fig. 1a) is one of these stable rearrangement products
of allicin.
Ajoene and its related polysulfane family members
have been shown to counter the different stages of can-
cer. In this regard, they inhibit tumour initiation by vari-
ous chemical carcinogens (reviewed in [4]), and counter
tumour growth by inhibiting proliferation and inducing
apoptosis in growing cancer cells (reviewed in [5, 6]).
Some of the garlic polysulfanes have been shown to in-
hibit the more advanced stages of cancer by countering
the metastatic process [7–10]. Ajoene displays attractive
therapeutic properties, being cytotoxic to cultured can-
cer cells in the low micromolar range [9, 11–13], and
showing a level of selectivity for cancer over normal cells
[11–13] while being relatively non-toxic in vivo [14].
Ajoene has a rare vinyl disulfide functional group that
is seldom found in other natural products. Disulfides are
known in biological systems to undergo mixed disulfide
exchange reactions with biological thiols, and ajoene and
its related family members may mimic and interfere with
these processes. Indeed, a number of the garlic polysul-
fanes have been shown to spontaneously react with
glutathione to form GSS-allyl [15–17]. In vitro experi-
ments have demonstrated that certain proteins are tar-
geted and S-thiolated by garlic polysulfanes at a cysteine
residue [18–20]. We found that thiolysis exchange is re-
gioselective for ajoene [21], and unsymmetrical disulfides
[22], with the reaction appearing to be driven by the sta-
bility of the expelled leaving group [22]. In the case of
ajoene, the allylic sulfur is more electrophilic, and hence
the site of attack of the incoming thiol nucleophile (see
Fig. 1a). We previously synthesised a fluorescent dansyl
labelled ajoene analogue called dansyl-ajoene (DP) that
contains the fluorescent group strategically placed on
the allylic sulfur end of the disulfide in order to ensure its
transfer to a protein target during thiolysis exchange [23]
(Fig. 1b). We found that ajoene accumulates in the endo-
plasmic reticulum (ER) of cancer cells, where it interferes
with protein folding by S-thiolating the exposed cysteine
residues of newly synthesised proteins. This leads to an ac-
cumulation of misfolded protein aggregates, which acti-
vates the unfolded protein response and induces ER stress.
Guided by a gene microarray in treated WHCO1
oesophageal cancer cells, we found that the central regula-
tor of the cytotoxicity of the ajoene analogue bisPMB is
GADD34/CHOP [24], which is a transcription factor that
regulates the unfolded protein response [25, 26]. We
found that ajoene S-thiolates numerous proteins in cancer
cells [23] although only a handful of them have to date
been identified. The finding that ajoene has many targets
in cancer cells may not be surprising given that the garlic
polysulfanes are active on the different stages of cancer,
and broadly speaking, claim numerous health benefits.
Therefore, understanding the underlying mechanisms be-
hind the bioactivity of ajoene may be greatly facilitated by
identification of its cellular protein targets. In this study
we identify vimentin as a target that undergoes thiolysis
exchange with ajoene in cancer cells. We show that the
covalent modification of vimentin by ajoene disrupts the
vimentin filamentous network that in turn counters the
metastatic phenotype of MDA-MB-231 and HeLa cancer
cells. The finding that vimentin is targeted and disrupted
by ajoene supports the dietary role of ajoene in the protec-
tion and control of metastatic cancer.
Methods
Synthesis of Ajoene and Dansyl-Ajoene
Ajoene was synthesised according to the method of
Block et al [3] by refluxing allicin in aqueous acetone.
The E- and Z-isomers were then separated by silica gel
chromatography. Dansyl-ajoene (DP) was synthesised as
an E/Z-mixture and characterised according to our pre-
viously published method [23].
Cell lines and treatments
The MDA-MB-231 and HeLa cell lines were purchased
from ATCC (HTB-26 and CCL-2) and have been au-
thenticated by IDEXX Bioresearch, UK on the 3/1/2018
(for MDA-MB-231) and the 9/7/2016 (for HeLa). The
cells were found to be negative for mycoplasma prior to
conducting any experiments. The cells were cultured in
Dulbecco’s Modified Eagle medium according to our
previously published methods [24]. Cells were seeded at
the specified density and allowed to attach overnight
prior to adding ajoene or dansyl-ajoene.
Immunoblot analysis
For detection of vimentin protein from MDA-MB-231
and HeLa cell lysates by immunoblot, standard protocols
according to our previously published works were ap-
plied [24]. After separation of proteins by SDS-PAGE,
proteins were transferred to a 0.2 μm nitrocellulose
membranes (Bio-Rad) using conventional methods. After
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blocking with 5% non-fat milk, the membranes were in-
cubated with the following primary antibodies overnight
at 4 °C: anti-vimentin (V9) (1:1000, Santa Cruz for V9
and H84 and Sigma-Aldrich for V4630), anti-GAPDH
(1:1000, Santa Cruz). Specific proteins were detected
using appropriate horseradish peroxidase-conjugated
secondary antibodies and the LumiGLO chemilumines-
cent reagent (KPL, Biocom Biotech). A protein ladder
(Thermo Fisher Scientific, Life Technologies) was used
to estimate the molecular weight of proteins. Proteins
were visualised using the UVP BioSpectrum™500 Im-
aging System (UVP, LCC Upland, CA, USA), captured
by the CCD camera (Canon Inc) and analysed with the
VisionWorks LS Acquisition analysis software (UVP, LCC
Upland, USA). For detection of recombinant vimentin
protein by immunoblot, the same protocol as above was
applied with the following deviation. Recombinant vimen-
tin (5 μg, Peprotech, USA) was made up to 1 μM in PBS,
pH 7.4 and treated with DP (100 μM) in 0.1% DMSO for
30min at room temperature. The untreated sample was
treated with 0.1% DMSO alone. Samples were then boiled
at 95 °C for 5 min with or without 100mM DTT (Sig-
ma-Aldrich). The immunoblot was then run as described
above and probed with an anti-dansyl primary antibody
(1:7500, molecular probes).
2D gel electrophoresis
The 2D gel electrophoresis was performed using 7 cm
immobilized pH gradient (IPG) strips (Bio-Rad) with a
pH range of 3–10. The total protein lysate collected
A
B
C
D
Fig. 1 Purification and Identification of Vimentin from DP-treated MDA-MB-231 cells. Proposed disulfide exchange reaction occurring between a
cysteine sulfhydryl group on a target protein with (a) Z-ajoene (ZA) or its analogue (b) dansyl-ajoene (DP). (c) Lysate collected from MDA-MB-231
breast cancer cells treated with 25 μM ZA or DP show many dansyl-labelled proteins by immunoblot when probed with an anti-dansyl primary
antibody in the DP-treated sample only. The experiment was performed under non-reducing conditions. (d) Separation of the dansyl-labelled
proteins in MDA-MB-231 cell lysate by 2D gel electrophoresis under non-reducing conditions. A predominant band (circled) was observed in the
immunoblot which was excised from the corresponding gel and identified by MALDI-TOF MS/MS to be vimentin
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from MDA-MB-231 cells treated with 25 μM DP for 24
h as described above and containing the dansyl-labelled
proteins was dissolved under non-reducing conditions in
urea lysis buffer (8M urea, 4% CHAPS, 0.5% Triton
X-100, 1x protease inhibitor cocktail tablet (Sigma-Al-
drich) and solubilised by gentle agitation on a vortex for
40 min at 20 °C. The protein was quantified using a
modified Bradford method [27]. A total of 250 μg pro-
tein together with 0.001% bromophenol blue and 1%
carrier ampholytes (Bio-Rad) in a volume of 100 μL was
loaded on the IPG strips which were rehydrated over-
night at 20 °C. The electrofocusing was performed using
a Protean IEF Cell (Bio-Rad) with a maximum current of
50 μA per strip and the following settings: 250 V linear
voltage for 20 min; 400 V linear voltage for 2 h and a
final step of 20,000 (Vh) with a maximum current of
50 μA per strip. The IPG strips were then equilibrated,
under non-reducing conditions, in equilibration buffer
(6M urea, 0.375M Tris HCl (pH 8.8), 2% SDS, 20% gly-
cerol and 0.00 1% bromophenol blue) for 10 min,
followed by a brief wash in distilled water, and equili-
brated again before separation on a native SDS-PAGE
gel. Two protein loaded IPG strips were separated in du-
plicate. One of them was then subjected to the
2D-immunoblot analyses with the anti-dansyl antibody,
as described above, while the other was used for excision
of the corresponding protein spots identified using the
2D-immunoblot for MALDI-TOF MS/MS analyses.
Proteolytic analysis: 2D gel electrophoresis
Gel pieces prepared above were destained with 200 mM
NH4HCO3:acetonitrile 50:50 (Sigma- Aldrich) until
clear. Samples were dehydrated and desiccated before
reduction with 2 mM triscarboxyethyl phosphine (TCEP;
Fluka) in 25 mM NH4HCO3 for 15 min at room
temperature with agitation. Excess TCEP was removed
and the samples again dehydrated. Cysteine residues
were carbamidomethylated with 20 mM iodoacetamide
(Sigma-Aldrich) in 25mM NH4HCO3 for 30 min at
room temperature in the dark. After carbamidomethyla-
tion the samples were dehydrated and washed with 25
mM NH4HCO3 followed by another dehydration step.
Proteins were digested by rehydrating the samples in
trypsin (Promega) at 20 ng/μL and incubating at 37 °C
overnight. Peptides were extracted from the gel pieces
once with 50 μL 0.1% trifluoroacetic acid (TFA) (Sig-
ma-Aldrich). The samples were dried and dissolved in
0.1% TFA, and then purified and concentrated using a
C18 ZipTip according to the manufacturers instruction.
The purified samples were eluted with 5 mg/mL
α-cyano-4-hydroxycinamic acid in 50% ACN:H2O con-
taining 0.1% TFA and spotted manually onto a MALDI
target plate. MALDI-TOF MS/MS was performed using
a 4800 MALDI TOF/TOF system (AB SCIEX) with
instrument control through 4000 Series Explorer. Parent
spectra were acquired in reflector positive mode at a
laser intensity of 4000 arbitrary units using 600 laser
shots per spectrum. The scan range of m/z = 800–4000
was used with a grid voltage of 16 kV. Spectra were in-
ternally calibrated using trypsin autolytic fragments.
Fragmentation data was acquired in positive mode with
a deceleration voltage of 1 kV. The spectra were ac-
quired with a laser intensity of 4500 arbitrary units and
1600 shots per spectrum. Database interrogation was
performed with the Mascot algorithm using the MSDB
database on a GPS workstation.
Proteolytic analysis: Recombinant vimentin
Purified recombinant vimentin protein, treated with ZA
or DP, was prepared as described in 2.3 above. These
proteins were run on SDS-PAGE, stained with coomas-
sie and the identified bands were excised from the gel.
Gel pieces were treated with Trypsin (Promega) at a final
trypsin:protein ratio of 1:20 made up to 50 μL with 50
mM NH4HCO3 (Sigma-Aldrich). Samples were digested
for 18 h at 37 °C. Peptides were then dried by vacuum
centrifugation and resuspended in 0.1% formic acid (Sig-
ma-Aldrich) and 2.5% acetonitrile (Anatech) to a final
concentration of 500 ng/μL. Samples were then stored at
− 80 °C until analysis. Nano-RP LC chromatography was
performed using a Dionex Ultimate 3000 nano-HPLC
system. LC-MS/MS analysis was conducted with a
Q-Exactive quadrupole-Orbitrap mass spectrometer
(Thermo Fisher Scientific) coupled with a Dionex Ultim-
ate 3000 nano-HPLC system. The mobile phases con-
sisted of solvent A (0.1% formic acid in water) and
solvent B (100% CH3CN, 0.1% formic acid). The HPLC
fractionated peptides were dissolved in sample loading
buffer (2.5% CH3CN, 0.1% formic acid) and loaded on a
C18 trap column (100 μm× 20mm × 5 μm). Chromato-
graphic separation was performed with a C18 column
(75 μm× 250mm× 3.6 μm). The mass spectrometer was
operated in positive ion mode with a capillary temperature
of 250 °C and an applied electrospray voltage of 1.95 kV.
Database interrogation was performed by CPGR with the
Mascot algorithm using the MSDB database on a GPS
workstation.
Cellular viability assay
Cytotoxicity of ZA was evaluated using the standard
MTT cellular viability assay according to our previously
published methods [23, 24].
Immunofluorescence
Cells were immunostained according to our previously
published methods [23]. Briefly, MDA-MB-231 or HeLa
cells were seeded on sterile coverslips in 6-well culture
dishes (5 × 105 cells per well) and allowed to settle
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overnight. Thereafter, the cells were treated with 20 μM
ZA in 0.1% DMSO or DMSO alone (control) for 6 h.
Cells were then washed with cold PBS (thrice), permea-
bilised with methanol at − 20 °C for 5 min and fixed in
4% paraformaldehyde (Sigma-Aldrich) for 5 min at room
temperature. Cell sections were then washed with PBS
(thrice), incubated in blocking solution (1% BSA in PBS)
for 1 h at room temperature, and then incubated with
the primary antibodies (anti-vimentin: V9, H84 or
V4630) diluted in blocking solution (1:100) overnight at
4 °C in the dark. Sections were then washed with PBS
and incubated with the relevant Cy3-labelled secondary
antibodies (Jacksons ImmunoResearch, supplied by
Amersham, South Africa) diluted in blocking solution
(1:500) for 90 min at room temperature in the dark. Sec-
tions were then washed with PBS (thrice), mounted
using Mowiol 4-88 (Sigma-Aldrich) and stored in the
dark at 4 °C until viewing by confocal scanning laser mi-
croscopy (Zeiss LSM510NLO).
Vimentin siRNA transfection
MDA-MB-231 or HeLa cells were seeded in 6-well cul-
ture dishes (1 × 105 cells per well) and cultured as de-
scribed in the general protocol above. The following day,
the cells were transfected with 50 nM (MDA-MB-231)
or 100 nM (HeLa) vimentin siRNA (Silencer® Select, Life
Technologies), using Transfectin Lipid reagent (Bio-Rad)
according to the manufacturer’s instruction. After 6 h for
MDA-MB-231, and 72 h for HeLa, medium containing
the transfection mixture was replaced by fresh culture
medium containing 10% FBS and the cells were incu-
bated for 24 h at which time the cells were then used in
the wound healing and invasion assays described in the
next section. Lysates from these cells were prepared and
applied to immunoblotting as described above.
Vimentin overexpression
MDA-MB-231 cells (5 × 105) or HeLa cells (1 × 105)
were seeded in 6-well culture dishes and allowed to at-
tach overnight. The following day, cells were transiently
transfected with 1 μg of human vimentin cDNA cloned
into pCMV3 (Sino Biological Inc.) using TransFectin
lipid reagent (Bio-Rad) according to the manufacturer’s
instructions. 4 h later the media containing the transfec-
tion mixture was replaced with fresh media containing
10 μM Z-ajoene in 0.1% DMSO or 0.1% DMSO alone
which was incubated with the cells for a further 24 h.
Wound healing migration assay
MDA-MB-231 cells (5 × 105) or HeLa cells (1 × 105)
were seeded in 6-well culture dishes and allowed to at-
tach overnight. Cells transfected with vimentin siRNA or
with pCMV3-vimentin were simultaneously prepared
and cultured as described in 2.9 or 2.10 above. After the
treatment, several lines were drawn underneath the dishes
with a marker as a reference line for wound measurement.
Three parallel scratch wounds were then made using a
yellow plastic tip. The cells were washed twice with PBS
to remove debris, thereafter fresh media was added.
Untransfected and transfected cells were then treated with
either 0.1% v/v DMSO or 10 μM ZA in 0.1% v/v DMSO
for 24 h. Images of the cells were taken at the place of the
wound at 0 h and 24 h. The wounds were observed by
phase contrast using an Olympus CKX41 inverted micro-
scope analysed with AnalySIS getIT software (Olympus,
Tokyo, Japan).
Transwell invasion assay
MDA-MB-231 cells or HeLa cells were transfected with
siRNA as described in 2.9 above and cultured overnight
in preparation for the transwell invasion assay. Matrigel
(BD Biosciences) was thawed overnight at 4 °C. Trans-
well 6-well plates with permeable cell culture inserts of
12 mm diameter with 8 μm pores (Corning) were also
chilled to 4 °C. Matrigel was diluted to 2mg/mL using
serum-free DMEM. Then matrigel (100 μL) was added
to the upper compartment of the insert, and the plates
were incubated at 37 °C for 2 h to solidify the matrigel.
Untransfected and transfected MDA-MB-231 and HeLa
cells were trypsinised and resuspended in DMEM. Media
was added to both the bottom well (DMEM containing
10% FBS as attractant) and the upper compartment of
the insert (DMEM containing 1% FBS). MDA-MB-231
cells (1 × 105) and HeLa cells (1 × 105) were then added
to the upper compartment and allowed to attach for 5 h
before treatment with ZA (10 μM) in 0.1% v/v DMSO or
0.1% v/v DMSO alone for 24 h. The cells and the matri-
gel in the upper compartment were then removed gently
by wiping with a cotton swab. Those cells on the lower
side of the insert membrane were fixed with 5% glutaral-
dehyde for 10 min at room temperature. The cells were
then stained with 1% crystal violet in 2% ethanol at room
temperature for 20 min. Thereafter the inserts were
immersed thrice in water and dried. The number of cells
that invaded through the matrigel were counted in four
different fields by visual observation using an Olympus
CKX41 inverted microscope analysed with AnalySIS
getIT software (Olympus, Tokyo, Japan).
Computational modelling of vimentin
The structure of the vimentin tetramer PDBID 3KLT
was chosen, prepared and modelled using Schrödinger
(Release 2017–2 with Maestro, Protein Preparation Wiz-
ard, Epik and Jaguar) [28–30]. Empirical pKa calcula-
tions, and rigid coordinate QM scans were carried out
for cysteine and for cysteine within a short sequence of
each chain of vimentin. Empirical pKa calculations were
conducted using Epik with default settings at pH 7.
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There is a limit on the number of atoms (500) that can be
used in these calculations, the largest system used was the
sequence RQVQSLTCEVDALK (chains A and B included).
Calculations were carried out for cysteine, cysteine in the
sequence RQVQSLTCEVDALK and cysteine in the se-
quence TCE. Scans over the C-C-C-S and C-C-S-H dihe-
dral angles were carried out to map the potential energy
landscape for each of the cysteine’s in vimentin. These
scans were completed using Jaguar with density functional
theory (DFT) and the basis B3LYP/6-31G**.
Statistical analysis
The data was analysed using 1-way ANOVA, multiple
comparisons to ascertain the statistical significant differ-
ences between untreated and treated samples. Graphpad
prism software version 6 was used to assess the signifi-
cance. P < 0.05 samples were considered significant where
* P-value < 0.05; ** P-value < 0.01; *** P-value < 0.001.
Results
Ajoene targets vimentin in MDA-MB-231 cells
Previous structure-activity studies in our laboratory have
identified the vinyl disulfide functional group to be the
ajoene pharmacophore that is responsible for cancer cell
cytotoxicity [21]. Additionally, we found that the vinyl
group plays an important role in enhancing this activity
through resonance-stabilisation of the enethiolate leav-
ing group [21, 22]. We further found that the allyl side
groups in ajoene are not critical for its cytotoxicity and
can be substituted without affecting activity and in some
cases improving its activity. Based on these insights, we
synthesised a dansyl-labelled ajoene probe called DP
[23]. The dansyl label was placed onto the allyl sulfur
end to ensure transfer to the protein targets during thio-
lysis exchange (see Fig. 1B for the scheme). DP was
found to be cytotoxic to MDA-MB-231 breast cancer
cells with a cytotoxicity IC50 of 21 ± 6.2 μM [23], which
is in the same range as the parent Z-ajoene (ZA) of 14 ±
2 μM [12]. We therefore treated MDA-MB-231 breast
cancer cells with 25 μM DP or ZA for 24 h and the lys-
ate was collected, separated by SDS-PAGE and trans-
ferred to a nitrocellulose membrane under non-reducing
conditions to avoid any cleavage of the disulfide bond
and the dansyl label from its target during processing.
Any proteins covalently linked to a dansyl group were
visualised using an anti-dansyl antibody. Many proteins
were found to be dansylated in MDA-MB-231 breast
cancer cells while no proteins were detectable in the
ZA-treated control sample as expected (Fig. 1c). We had
previously established by competition assay that ZA and
DP share the same targets [23], and since very few of
these targets are known, we attempted to separate and
identify them by 2D gel electrophoresis. Although the
non-reducing conditions used for this 2D gel were not
optimal for separation as the proteins remain partly folded
with their disulfide bonds intact, the separation neverthe-
less identified a few spots, especially below pH 6 and in
the 50 to 70 kDa range (Fig. 1d). A prominent band (cir-
cled) was excised from the gel and identified by
MALDI-TOF MS/MS to be the 57 kDa protein vimentin.
Validation of the vimentin target
In order to validate that the vimentin protein isolated from
MDA-MB-231 cell lysate is a true target of ajoene, we per-
formed a series of experiments on the pure recombinant
protein. Recombinant vimentin was incubated with 100 μM
DP or ZA in PBS buffer for 1 h. The protein was then mi-
grated on SDS-PAGE and transferred to a membrane for
visualisation of any dansyl-incorporation using the
anti-dansyl antibody (in the case of DP treatment, see
Fig. 2a). The dansyl label from DP was clearly seen to be
covalently attached to the vimentin protein under
non-reducing conditions (−DTT). In agreement with the
attachment of the dansyl label through a disulfide bond, it
was cleaved following treatment of the protein with the re-
ducing agent dithiothreitol (+DTT). To identify the specific
ajoene binding site amino acid on the vimentin protein,
high resolution mass spectrometry was performed. Recom-
binant vimentin treated with ZA or DP, was excised from
the gel and digested with trypsin to produce vimentin pep-
tide fragments. The peptides were then separated chro-
matographically using a C18 column and identified by
MALDI-TOF MS/MS mass spectrometry. Database inter-
rogation was performed to identify the peptide fragment
containing Cys-328 that was found carrying a 2+ charge
(Fig. 2b). In the treated samples, this Cys-328 containing
fragment was identified carrying the expected mass from
ZA or DP (see Fig. 2c and Additional file 1: Figure S1).
Taken together, these results support the finding that
vimentin is a target of ajoene in MDA-MB-231 cells and
that ajoene covalently binds to vimentin at Cys-328 by
S-thiolation.
Ajoene disrupts the vimentin filament network in cells
The S-thiolation of vimentin by ajoene may be seen as a
post-translational modification that leads to a change in
the overall protein structure. Vimentin is a structural
protein and a member of the intermediate filament family
of proteins that is ubiquitously expressed in normal mes-
enchymal cells [31]. Vimentin monomers self-assemble
into filaments that form scaffolds and organise the cyto-
plasmic space to define and maintain the cellular architec-
ture [32]. Vimentin is considered a cancer marker as it is
overexpressed in most epithelial cancers undergoing epi-
thelial to mesenchymal transition (EMT), and its overex-
pression correlates well with accelerated tumour growth,
invasion, angiogenesis and poor prognosis [33–35]. We
investigated whether the covalent attachment of ZA to
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vimentin may affect the filamentous network. Non-cytotoxic
treatment conditions of ZA were first selected as it was not
the intention to induce apoptosis in cells, which would lead
to protein degradation and an impairment of vimentin func-
tion by virtue of apoptosis. We first assessed cell viability of
two cancer cell lines, MDA-MB-231 and HeLa cells, using
the MTT assay and selected two treatment conditions for
further investigations: 20 μM ZA for 6 h (treatment condi-
tion 1); or 10 μM ZA for 24 h (treatment condition 2) (Fig.
3b and e). Although the cells under these treatment condi-
tions were considered viable by the MTT assay, the cellular
morphology for the HeLa cells, but not for the
MDA-MB-231 cells, appeared altered (shown for treatment
condition 2, Fig. 3a and d). The treated cells appeared
slightly shrunken and sharpened at the edges (Fig. 3d, see
arrow), although the proliferation rates were unchanged.
Treated cells were then fixed and immunostained with dif-
ferent vimentin primary antibodies to visualise the cellular
A
B
C
Fig. 2 Validation of Vimentin as an Ajoene Target. (a) Immunoblot of human recombinant vimentin treated with DP (100 μM) in the absence or
presence of DTT (100 mM), probed with a primary anti-dansyl and anti-vimentin (H-84) antibody. (b) Human recombinant vimentin was treated
with 100 μM ZA or DP and purified by SDS-PAGE. The band excised from the gel was digested with trypsin and fragments were identified by MS/
MS MALDI-TOFF mass spectrometry. The Cys-328 containing fragment qvqsltcevdalk was detected in the control and treated samples carrying a
2+ charge where m/z = [M + 2H]2+. (c) In the samples treated with ZA or DP, the predicted m/z ratio of the modified fragment was observed
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vimentin network (Fig. 3c and f). In the control cells, de-
fined networks of filamentous vimentin fibres were observed
with the different antibodies for vimentin. V9 recognises full
length vimentin and these cells showed distinct filaments.
H84 recognises an epitope corresponding to amino acids
1-84 mapping at the N-terminus of vimentin which also ap-
pears filamentous but more diffuse. V4630 staining did not
appear filamentous but more granular and dispersed uni-
formly throughout the cytoplasm. Using either of the anti-
bodies, the cells treated with ZA showed condensed
filaments that did not extend far into the intracellular space.
The effect appeared most pronounced when viewed with
the antibody for intracellular vimentin (V9) which is the
antibody most commonly used to immunostain vimentin,
although in all cases, the filaments appeared shrunken and
condensed. An appropriate conclusion is that ZA may be
inhibiting the proper formation of the vimentin filament
network in a way that is important in organising the cyto-
plasmic space, this could explain the somewhat shrunken
morphology of treated HeLa cells.
Ajoene induces increased vimentin expression
We investigated whether ajoene may have an effect on the
expression levels of vimentin protein by treating MDA-
MB-231 or HeLa cells with ZA under non-cytotoxic condi-
tions. At various time-points up to 8 h, cell lysate was col-
lected and total vimentin protein expression was quantified
by immunoblot. Surprisingly, and apparently contra-
dictory to the role that vimentin plays in metastasis,
A
B
E
C
D F
Fig. 3 Ajoene Disrupts the Vimentin Filament Network in MDA-MB-231 and HeLa cells. 40x Phase contrast images of MDA-MB-231 (a) or HeLa (d) cells
treated with DMSO (control) or 10 μM ZA in DMSO for 24 h. Cell viability assay: MDA-MB-231 (b) or HeLa (e) cells treated with DMSO (control) or with ZA
(0, 5, 10, 20 or 40 μM) for 6 h or 24 h. Immunofluorescence: MDA-MB-231 (c) or HeLa (f) cells treated with 20 μM ZA for 6 h, then fixed and immunostained
with vimentin primary antibodies (V9, H84 or V4630). Control cells treated with DMSO alone. Images obtained by confocal scanning laser microscopy
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a time-dependent increase in total vimentin protein
was observed (Fig. 4).
Ajoene inhibits invasion and migration
Tumour cells acquire the ability to infiltrate blood or lymph-
atic vessels via EMT, which is widely believed to increase
tumour aggressiveness and aid in metastasis. These events
are facilitated by the reduction in the cell-cell adhesion mol-
ecule E-cadherin; and upregulation of the more plastic mes-
enchymal proteins such as vimentin, N-cadherin, matrix
metalloproteinase (MMP)-2, and smooth muscle actin [36].
Vimentin is overexpressed in many cancers and its overex-
pression is frequently associated with an increased migratory
and invasive capacity [33]. Moreover, some of the garlic
organosulfur compounds are reported to inhibit the invasion
and migration of cancer cells, although this has not been
shown for ajoene. Thus, we decided to investigate whether
ajoene may exert anti-metastatic activity in cancer cells by
looking at the MDA-MB-231 and HeLa cell lines. To this
end, MDA-MB-231 or Hela cells were treated with a
non-cytotoxic concentration of ZA, and anti-metastatic ac-
tivity was assessed by the wound healing migration assay
(Fig. 5a-d) as well as by a transwell invasion assay (Fig. 5e
and f). The migration experiment involves introducing a
scratch wound into the cell monolayer and quantifying the
ability of the cells to migrate into this wound in the presence
of ZA. In the invasion assay, the ability of the cancer cells to
degrade and move through the transwell membrane matrix
is assessed. As a control, we included in these experiments
cells in which vimentin expression had been transiently si-
lenced with vimentin siRNA. Importantly, it was found that
cells lacking the vimentin protein were unable to migrate
into the scratch wound, findings that are consistent with the
role of vimentin in EMT and that confirm a previous litera-
ture report [37] (Fig. 5a-d). These cells also showed much
decreased ability to break down and invade the membrane
matrix (Fig. 5e and f). The presence of ZA was found to in-
hibit the migration of cells into the scratch wound, and to
inhibit invasion of the cells through the membrane. Inter-
estingly, when ZA was added to cells that lacked vimentin
protein (siVim cells), no further reduction in invasion or
migration was observed (compare columns C and D). This
suggests the cell target of ajoene inhibition of cell motility
and invasion is vimentin. In comparing the effects of add-
ing ZA alone, to vimentin deficient cells (compare col-
umns B and D) a small significant decrease was seen in
the wound healing assay but not in the invasion assay.
This additive effect may be explained by the observation
that ZA compromises the vimentin network, although it
does not completely dismantle it (as observed in immuno-
fluorescence experiments in Fig. 3), while depleting
vimentin has a more pronounced effect and is statistically
significant in the wound healing experiment. Silencing
vimentin blocks more than ZA in the wound healing ex-
periment but in invasion ZA is more potent, possibly be-
cause it may also inhibit other processes associated with
EMT which is supported in the literature for other garlic
organosulfur compounds.
Fig. 4 Ajoene Induces Increased Expression of Vimentin. MDA-MB-231 (top) or HeLa (bottom) cells were treated with either DMSO (control) or 10 μM
ZA in DMSO up to 8 h. Proteins collected from the cell lysate were separated by SDS-PAGE and vimentin expression was quantified by immunoblot
probed with a primary anti-vimentin antibody (V9). The blots shown are a representative experiment of two independent determinations
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Fig. 5 (See legend on next page.)
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Ajoene partially rescues the phenotype of vimentin
overexpression
To further investigate whether vimentin is a functionally
relevant target of ajoene’s anti-metastatic activity, we transi-
ently overexpressed vimentin in HeLa and MDA-MB-231
cells (Fig. 6a). A scratch wound was then introduced into
the cell monolayer, followed by addition of 10 μM Z-ajoene
in DMSO or DMSO alone for 24 h. In agreement with the
literature [33], vimentin overexpression was found to in-
crease the migratory potential of both cancer cell lines up
to 130%. Interestingly, ajoene completely countered the in-
creased migratory potential in both cell lines, caused by
vimentin overexpression (Fig. 6). This experiment strongly
suggests that the anti-migratory activity of ajoene is medi-
ated through the vimentin target.
Computational modelling of the vimentin tetramer
It is proposed that vimentin monomers assemble into par-
allel dimers that in turn assemble antiparallel and staggered
into tetramers which are considered the structural units for
vimentin polymerisation [36–38]. The vimentin tetramer
(Protein data base 3KLT) which is composed of four
vimentin chains was chosen, prepared and computationally
modelled using Schrödinger modelling software (Fig. 7). Al-
ternative PDB structures were considered to be incomplete
by either missing the cysteine or present as vimentin di-
mers only. For a cysteine residue to be reactive we expect it
to be accessible. From a visual inspection, there is no con-
cave binding domain for substrates in the vicinity of
Cys-328; however all four of the cysteine residues, found at
the two termini of the tetramer, appear exposed and point-
ing outwards. A cysteine thiolate is a superior nucleophile
to a thiol and the ease of deprotonation is reflected in its
pKa. Empirical pKa, calculations, and rigid coordinate
quantum mechanical scans were carried out for cysteine
and cysteine from the selected sequence TCE. Empirical
pKa, was also calculated for cysteine in the sequence
RQVQSLTCEVDALK. Scans over the cysteine CCCS and
(See figure on previous page.)
Fig. 5 Ajoene Inhibits the Invasion and Migration of MDA-MB-231 and HeLa Cells. Wound healing assay: Following introduction of a scratch
wound into the cell layer of (a and c) MDA-MB-231 or (b and d) HeLa cells; native cells, or cells silenced for vimentin expression were incubated
with 10 μM ZA in DMSO or DMSO alone for 24 h. Migration into the wound was then quantified using Image J software. Transwell invasion and
migration assay: (e) MDA-MB-231 cells or (f) HeLa cells were transfected with vimentin siRNA and treated as described above for 24 h. The ability
of cells to invade and migrate through the matrigel membrane was quantified by counting the crystal violet stained cells, data displayed as
mean ± SD. The results of a single representative experiment is shown; however experiments were performed in duplicate
A
B C
Fig. 6 Ajoene Rescues the Enhanced Migratory Potential of Vimentin Overexpressing Cells. (a) Vimentin was transiently overexpressed using
human vimentin cDNA cloned into pCMV3, in both HeLa and MDA-MB-231 cells as shown and quantified by immunoblot. A scratch wound was
then introduced into MDA-MB-231 (b and d) or HeLa (c or e) cells and 10 μM ZA in DMSO or DMSO alone was incubated with the cells for 24 h.
Migration into the wound was then quantified using Image J software. The results of a single representative experiment is shown; however
experiments were performed in duplicate
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CCSH dihedral angles were carried out to map the poten-
tial energy landscape for each cysteine in vimentin. The
pKa of cysteine is 8.5 and a reduction in the pKa of a cyst-
eine residue requires assistance by amino acids in the sur-
rounding environment [38–40]. Catalytic cysteines, for
example in peroxiredoxins and protein tyrosine phospha-
tases, have very low pKa in the ranges 4.6 - 5.5 and 4.5 -
5.9, respectively [41, 42]. Nearby negatively charged amino
acids that may assist in this regard by general base catalysis
could include Glu-329 and Asp-331, and these were in-
cluded in the empirical calculations (as per sequence indi-
cated in Additional file 2: Figure S2). The empirical pKa
calculations were found to be very similar to the experi-
mental pKa for cysteine in all models (Additional file 2:
Table S1). A 14 amino acid sequence, RQVQSLTCEV-
DALK of chains A and B containing both Glu-329 and
Asp-331, had a slightly lower calculated pKa but no signifi-
cance can be assigned to this (8.47 ± 2.22). Although the
cysteine CCCS and CCSH torsion angles within the tetra-
mer crystal structure are very different (Additional file 2:
Table S1) further investigations of the energies over dihe-
dral conformations of each cysteine in chains A-D showed
that the low energy and high energy regions are similar in
all chains with the expected CCCS staggered low energy
conformations available (Additional file 2: Figure S2). We
therefore conclude that all cysteines are equally reactive in
the vimentin tetramer and that there is no obvious prefer-
ence for general base assisted catalysis to favour thiolate
formation. It would appear therefore that the apparent re-
activity of Cys-328 towards ajoene is dependent solely on
its accessibility.
Discussion
Cancer is a hyper-proliferative disease that results in
over six million deaths per year. Most malignancies are
diagnosed and treated at an advanced stage with poor
prognosis making cancer prevention an attractive inter-
vention strategy. Several lines of evidence suggest that
many cancers are preventable, as their causation is
largely exogenous, with diet and lifestyle playing an im-
portant role. In this regard, garlic is a medicinal plant
that has been used for centuries for its beneficial health
effects that include protection against cancer. Its anti-
cancer activity may be ascribed to the organosulfur com-
pounds that are found in crushed garlic preparations, of
which ajoene is a family member. These compounds
have been shown to inhibit different stages of cancer,
supporting our findings that ajoene has multiple protein
targets in cancer cells [23]. The majority of these targets
are ER-associated, as strong co-localisation was observed
between our fluorescently-labelled ajoene analogue, DP,
and dyes specific for the ER [23].
Fig. 7 Computational modelling of the Vimentin tetramer showing the environment of Cys-328. The structure of the vimentin tetramer (PDBID 3KLT)
was chosen, prepared and modelled using Schrödinger software. The structure of the tetramer is labelled and shown using a space filling
representation for chain (a) (grey) and modified cartoon representation for chains (b, c, d) (cyan, yellow and magenta), The four cysteine thiols are
coloured yellow and are exposed at the termini of the tetramer. The environment for the cysteine of each chain in the tetramer is illustrated. The thiol
hydrogen points in the direction of the glutamate in chain (a), towards the carbonyl oxygen in chains (c, d) and towards Gln-324 in chain (b)
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The thiol/disulfide exchange reaction between a pro-
tein sulfhydryl group and glutathione is well docu-
mented in biological systems [43, 44]. This process,
called glutathionylation, is reversible and occurs spon-
taneously under oxidative stress conditions, or can be
enzyme catalysed [43]. The capping of protein cysteine
residues with glutathione is thought to protect proteins
against irreversible oxidative damage, as well as being a
post-translational modification important in the regula-
tion of cellular functions [43–47]. The GSSG:GSH ratio
is an important indicator of the redox status of the cell,
and the non-enzymatically driven extent of protein glu-
tathionylation will vary accordingly: a higher ratio will
promote glutathionylation while a lower ratio will result
in deglutathionylation and release of GSH. It is reported
that approximately 50% of the glutathione in the ER is
bound to proteins via glutathionylation [48] compared
to less than 1% in other locations [49, 50] due to this or-
ganelle being more oxidising in nature. Indeed, it was in
the ER that ajoene was found to accumulate [23, 24].
The garlic polysulfanes, including ajoene, may S-thiolate
cysteine residues in redox-sensitive proteins in a manner
similar to glutathionylation [51], and this is supported
by our findings that ajoene S-thiolates numerous pro-
teins in cancer cells, possibly in competition with GSSG.
Based on the presence of a vinyl disulfide (as a better
leaving group due to resonance stabilisation of the
enethiolate released during thiolysis exchange), ajoene
would be expected to be a superior thiolating agent in
S-thiolation compared to GSSG. Therefore, proteins that
are susceptible to glutathionylation are probably the tar-
gets of ajoene. In support of this, the proteins identified
to date to be S-thiolated by garlic organosulfur com-
pounds (tubulin, glutathione reductase and sulfur trans-
ferases) are all proteins reported to be glutathionylated
[43, 47, 52, 53].
Here we report that vimentin is a newly identified target of
ajoene. Vimentin is important in maintaining the structural
integrity of normal cells and in epithelial-to-mesenchymal
transition. In cancer, vimentin is a driver of cancer progres-
sion and contributes to the invasive phenotype of metastatic
cancer cells [54, 55]. In addition, vimentin has been shown
to be a component of the attachment and uptake complex of
several viruses, for example HPV [56]. The Cys-328 residue
in vimentin has previously been identified as a site prone to
oxidative modification by small molecule electrophiles, an
example being withaferin A, a steroidal lactone found in the
medicinal plant Withania somnifera, that reacts via michael
addition of its enone with Cys-328 [57], and this modification
was found to mediate antiangiogenic effects [58]. In another
example, Cys-328 was found to be oxidatively modified by
the electrophilic signalling lipid PGA1 which contains the
cyclopentenone structural motif [59]. In the current study
we have found that the natural dietary compound ajoene
targets vimentin in metastatic MDA-MB-231 cells by cova-
lent oxidation at Cys-328. From a visual inspection of the
crystallised vimentin tetramer, there does not appear to be
any concave binding site for substrates in the vicinity of
Cys-328. This correlates with the observation that diverse
electrophilic structures that include a peptide, steroid, lipid
and a polysulfane are able to successfully access and oxidise
Cys-328. As we did not find any apparent preference for gen-
eral base assisted catalysis in the vicinity of Cys-328, and em-
pirical pKa calculations failed to reveal preference for thioate
formation of any of the cysteines in the tetramer. A reason-
able conclusion therefore is that the reactivity of Cys-328 to
diverse oxidising and electrophilic agents is probably due to
its accessibility.
Vimentin filaments are important in organising the
cellular architecture and are described as being dynamic,
motile and plastic [60–62]. These fluid properties pro-
vide mechanisms for their reorganisation and assembly
in response to the requirements of the cell; being it ad-
hesion, migration or signalling. The first level of organ-
isation is the formation of coiled dimers that are
arranged in parallel [63]. They assemble half-staggered
and anti-parallel in an A11 manner [64] into tetramers,
that are considered the basic structural units for further
vimentin polymerisation [61, 64, 65]. Any exchange be-
tween tetrameric units is dynamic and occurs end-to-end
at any point along the filament length [33, 66]. With cyst-
eine cross-linking agents, it has been possible to link to-
gether staggered vimentin dimers [67], and to crosslink
vimentin to other filament proteins [32, 68]. Pérez-Sala et
al found that crosslinking vimentin stabilises the intracel-
lular network and protects it from disruption by electro-
philic and oxidising agents [69] thereby showing how
reduced Cys-328 is important in the overall stabilisation
of the network. In the absence of crosslinking agents, the
inter-cysteine distance between tetramers is proposed to
be too long to support disulfide bond formation and elem-
ental zinc may bridge the two cysteine residues to stabilise
this network in vivo [69]. We show that ajoene oxidises
Cys-328 of vimentin in MDA-MB-231 and HeLa cells
which disrupts the filamentous network and affects the in-
vasive and migratory potential of these cells. Other mem-
bers of the garlic polysulfane family namely SAMC [7],
DADS [8, 10] and DATS [70] are reported to inhibit inva-
sion and migration in different cancer cell lines; and
SAMC [7, 71], SAC [72], DATS [70, 73] and ajoene [9]
have all been shown to inhibit metastasis in vivo in mouse
models for cancer [9]. While the antimetastatic activity for
ajoene has been demonstrated in vivo, this is the first re-
port to demonstrate it in cancer cell lines. Garlic organo-
sulfur compounds have been shown to reverse EMT by
inactivating the β-catenin pathway by increasing the ex-
pression of the epithelial marker E-cadherin, and decreas-
ing the expression of the mesenchymal markers vimentin,
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N-cadherin and snail [7, 8], as well as downregulating
MMP-2/9 [8, 70]. This is the first report that ajoene dir-
ectly targets and covalently modifies vimentin in cancer
cells and it is therefore not known whether vimentin tar-
geting also occurs for other garlic organosulfur com-
pounds; and conversely whether inhibition of other EMT
processes may also occur for ajoene.
Vimentin is a cancer marker that is overexpressed in
neoplasms undergoing epithelial to mesenchymal transi-
tion. Moreover, its overexpression correlates well with
the metastatic phenotype. Our finding that ajoene in-
creases the expression of vimentin in cancer cells is
therefore surprising and contradictory to the role that
vimentin plays in progression of metastatic disease. In-
deed, we found that artificial overexpression of vimentin
in both cancer cell lines caused enhanced migration up
to 130%. In support of ajoene binding to vimentin, and
inhibiting its proper function, the enhanced migratory
effect observed in vimentin overexpressing cells was
completely inhibited by ajoene. Therefore, although
ajoene causes a time-dependent increase in vimentin
expression, it is importantly inhibiting the vimentin-
dependent increase in migration. We argue that
ajoenes increased vimentin expression may be a re-
sponse to restore the malfunctioning vimentin net-
work. However, due to the continued presence of
ajoene, this newly synthesised vimentin does not lead
to enhanced migration (in fact reduced migration).
In other words, the newly synthesised vimentin does
not form functional filaments. A similar contradict-
ory effect has been observed before by Dirsch et al
[74]. In that report, ajoene was found to inhibit
Cox-2 enzyme activity with a simultaneous increase
in the Cox-2 protein and mRNA levels. To our
knowledge, our vimentin finding is therefore the sec-
ond example in the literature, where ajoene has been
found to target and inhibit a protein, with a simul-
taneous increase in its expression.
Conclusions
The ability of ajoene to covalently bind to Cys-328 of
vimentin in cancer cells, causes the filaments become
condensed and disrupted. This appears to also cause a
shrinking of the cellular morphology. Ajoene-treated
cancer cells are less able to migrate and invade the
membrane matrix than untreated cancer cells. This anti-
metastatic activity is related to the ability of ajoene to
bind to vimentin as removal of the target countered
ajoenes antimetastatic activity. Moreover, ajoene rescued
the enhanced migratory potential observed upon artifi-
cial vimentin overexpression. Taken together, the find-
ings support the role of ajoene as a natural dietary
phytochemical able to offer protection against metastatic
cancer, mediated through binding to the vimentin target.
Additional file
Additional file 1: Figure S1. Calculation of vimentin mass fragments.
The peptide QVQSLTCEVDALK containing Cys-328 was detected carrying
a 2+ charge. The predicted mass of the same fragment modified by DP
or ZA was then calculated accordingly. (PPTX 40 kb)
Additional file 2: Figure S2. Computational modelling of the torsional
conformational energies of the cysteine motifs extracted from the
vimentin tetramer. The structure of the vimentin tetramer (PDBID 3KLT)
was chosen, prepared and modelled using Schrödinger. A short
sequence motif (TCE) was chosen for chain A-D and this was modelled
using Jaguar’s rigid coordinate scan. The dihedrals C-C-C-S and C-C-S-H
define the conformational space of the cysteine. Maps for chain A-D are
shown with a duplicated phase space range for improved visualisation.
Low energy and high energy regions are similar in all chains. Table S1. A
summary of pKa predictions and torsional angles for model systems of
cysteine and cysteine in vimentin. (PPTX 377 kb)
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